NCT00132119View on ClinicalTrials.gov

Nalmefene Gambling Study: Study of Nalmefene HCl in the Treatment of Pathological Gambling

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

233

Participants

Timeline

Start Date

August 31, 2005

Primary Completion Date

August 31, 2006

Study Completion Date

August 31, 2006

Conditions
Pathological Gambling
Interventions
DRUG

nalmefene HCl

Nalmefene HCl film-coated tablets, 20 or 40 mg, administered orally once daily for 10 weeks.

OTHER

Placebo

Placebo tablet

Sponsors
All Listed Sponsors
lead

Somaxon Pharmaceuticals

INDUSTRY